The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 353:313-314 July 21, 2005 Number 3
NextNext

Familial Cancer and ARLTS1

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Calin, G. A.
-PubMed Citation
To the Editor: Calin et al. (April 21 issue)1 report on ARLTS1, a novel tumor-suppressor gene with proapoptotic characteristics and a member of the ADP-ribosylation factor family. It is proposed that a protein-truncating mutation (G446A) predisposes patients to cancer on the basis of the higher frequency of this allele among patients with familial cancer than among patients with sporadic tumors. The allele frequency was population-dependent, but when patient groups were compared with the control group, this heterogeneity was not accounted for. Using Fisher's exact test, we arrive at a P value of 0.56 instead of 0.02 when comparing familial and . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.